Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2024 (11)
  • 2023 (21)
  • 2022 (21)
  • 2021 (52)
  • 2020 (11)
  • 2011 (0)

Subject

  • Drug Trafficking (24)
  • Prescription Drugs (20)
  • Pharmaceuticals/Pharmacists/Physicians (19)
  • Synthetic drugs (19)
  • Seizures (Drugs/Property) (15)
  • Task Forces/Task Force Officers (15)
  • Diversion Division (12)
  • Major Law Enforcement Operation (11)
  • Arrests/Convictions - Major (9)
  • OCDETF/Task Force (8)
  • Outreach/Drug Prevention (7)
  • Overdose (7)
  • Guilty Plea (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Dark Web- Internet Trafficking (2)
  • Guns/Weapons (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Take Back Day (2)
  • Fake Pills (1)
  • Intelligence Division - Intelligence Products (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Oxycodone (58)
  • Marijuana (Cannabis) (52)
  • Synthetic Opioids (28)
  • Benzodiazepines (9)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • Hydromorphone (4)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • Steroids (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Opioids (52)

Field Division

  • Washington, DC (28)
  • Dallas (3)
  • Headquarters (3)
  • Miami (3)
  • Atlanta (2)
  • Chicago (2)
  • Houston (2)
  • New Jersey (2)
  • Seattle (2)
  • St. Louis (2)
  • Detroit (1)
  • New York (1)
  • San Francisco (1)
Clear All Results
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

November 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
November 30, 2021
PRESS RELEASE

Hanover Man Pleads Guilty to Distribution of Fentanyl, Cocaine, and Other Drugs Shipped Through the Mail from California to Maryland

November 22, 2021
Baltimore, Md., – Dwight Antonio Pitts, age 47, of Hanover, Maryland, pleaded guilty on November 19, 2021, to charges related to his participation in a drug distribution conspiracy involving large amounts of fentanyl, cocaine, and other drugs, shipped through the U.S. Mail from California to Maryland. The guilty plea was...
November 22, 2021
PRESS RELEASE

Post Falls Doctor Pays $110,000 for Overprescribing Opioids

November 22, 2021
COEUR D’ALENE – Dr. Eric Benson, an internist practicing medicine in Post Falls, Idaho, agreed to pay $110,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients between 2014-2021. The settlement, which was based in part on Dr. Benson’s ability to pay, also restricts the...
November 22, 2021
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

November 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
November 19, 2021
PRESS RELEASE

Doctor Convicted of Illegally Prescribing Opioids to Patients

November 19, 2021
SACRAMENTO, Calif. — Physician Edmund Kemprud, 78, of Dublin, was convicted today of 14 counts of illegally prescribing opioids and other controlled substances patients, Acting U.S. Attorney Phillip A. Talbert announced. According to evidence presented at trial, Kemprud was a physician licensed to practice medicine in California and worked in...
November 19, 2021
PRESS RELEASE

Drug Dealer Pleads Guilty to Heroin Distribution and Admits That Heroin He Distributed Resulted in a Fatal Overdose

November 18, 2021
Greenbelt, Md., – Edwin Kerry Smith, age 43, of Silver Spring, Maryland, pleaded guilty today to possession with intent to distribute a controlled substance and admitted that heroin he distributed to one victim resulted in the victim’s fatal overdose. The guilty plea was announced by Jarod Forget, Special Agent in...
November 18, 2021
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

November 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
November 17, 2021
PRESS RELEASE

Pharmacist Found Guilty of Illegally Dispensing and Distributing Controlled Substances

November 10, 2021
ATLANTA - Thomas Ukoshovbera A. Gbenedio has been convicted by a federal jury of illegally dispensing and distributing controlled substances from his pharmacy. “Removing and ultimately eliminating healthcare providers who unlawfully dispense pharmaceutical products for non-medical reasons is an important part of DEA’s mission,” said Special Agent in Charge of...
November 10, 2021
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Brings in 745,000 Pounds of Unneeded Medications, Continues Fight Against Opioid Epidemic

November 01, 2021
Washington, D.C., – The DEA, along with its law enforcement partners, removed close to 745,000 pounds of unneeded prescriptions from medicine cabinets across the country this past Saturday, October 23rd, as part of DEA’s ongoing commitment to turn the tide against the U.S. opioid epidemic. Following last month’s 21st National...
November 01, 2021
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

November 01, 2021
MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
November 01, 2021
Showing 1 - 10 of 52 results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster